Paper Details

  1. Home
  2. Paper Details

Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.

Author: BresslerN M, BresslerS B, SchachatA P, WeiszJ M

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Topical ketorolac ophthalmic drops prescribed four times a day improved visual acuity and resolved edema in 70% of patients with pseudophakic cystoid macular edema identified more than 24 months after cataract surgery. However, ketorolac probably requires persistent use to maintain improvement.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To evaluate whether ketorolac ophthalmic drops prescribed four times a day can be associated with improved visual acuity and prompt resolution of edema for patients with pseudophakic cystoid macular edema identified more than 24 months after cataract surgery. DESIGN: Prospective, nonrand...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/S0161-6420(99)90366-4

データ提供：米国国立医学図書館（NLM）

Ketorolac for Pseudophakic Cystoid Macular Edema: A Promising Treatment

Ophthalmology is a vast and fascinating field, with a constant pursuit of innovative solutions for various eye conditions. Pseudophakic cystoid macular edema, a condition characterized by fluid buildup in the macula following cataract surgery, poses a significant challenge for ophthalmologists. This study, utilizing a prospective, non-randomized, comparative design, delves into the potential of ketorolac ophthalmic drops in managing this condition. The researchers observed a significant improvement in visual acuity in 70% of the patients, with complete or partial resolution of the edema. This highlights the therapeutic potential of ketorolac in addressing this particular type of macular edema.

Ketorolac Offers Hope for Improved Vision

The study found that ketorolac treatment significantly improved visual acuity in 70% of patients with pseudophakic cystoid macular edema. This improvement was observed within 3 months of treatment initiation, showcasing the rapid efficacy of ketorolac. Furthermore, the study indicated that ketorolac might require continuous use to maintain the positive effects. This finding is crucial for patient management, ensuring that treatment plans are adapted to maintain the benefits observed.

Keeping an Eye on Macular Health

Pseudophakic cystoid macular edema can impact vision, potentially affecting daily activities. While ketorolac shows promise in managing this condition, it's crucial to understand that it may require continuous use to maintain its effectiveness. Regularly scheduled eye check-ups are essential for early detection of any changes or complications, ensuring optimal visual health. Remember, the desert may be vast, but with consistent care, we can navigate its challenges and keep our vision clear.

Dr.Camel's Conclusion

Ketorolac ophthalmic drops hold promise as a treatment for pseudophakic cystoid macular edema, demonstrating improvement in visual acuity for a significant portion of patients. However, ongoing use may be required to maintain these positive effects. As a wise camel traversing the vast desert, I urge you to embrace preventative measures and prioritize regular eye examinations to ensure the well-being of your vision.

Date :
  1. Date Completed 1999-09-20
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

10485530

DOI: Digital Object Identifier

10.1016/S0161-6420(99)90366-4

Related Literature

Article Analysis
・Effects of ketorolac ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.